Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as Peter Thiel jumps on the board and IPO rumors heat up
AbCellera Biologics is stepping onto Regeneron’s turf, putting down $90 million in cash to buy out Trianni and its humanized …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
